INGN
Inogen Inc

1,478
Mkt Cap
$154.2M
Volume
11,461.00
52W High
$11.94
52W Low
$5.48
PE Ratio
-5.66
INGN Fundamentals
Price
$5.84
Prev Close
$5.68
Open
$5.68
50D MA
$6.33
Beta
1.30
Avg. Volume
220,074.35
EPS (Annual)
-$1.52
P/B
0.78
Rev/Employee
$438,257.18
$118.90
Loading...
Loading...
News
all
press releases
Inogen Q4 Earnings Call Highlights
Inogen (NASDAQ:INGN) executives highlighted improving profitability, international momentum, and a broadened product portfolio during the company's fourth-quarter 2025 earnings call held February 24...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of +27.78% and -0.34%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13h ago
News Placeholder
Inogen (NASDAQ:INGN) Posts Earnings Results, Beats Expectations By $0.21 EPS
Inogen (NASDAQ:INGN - Get Free Report) announced its quarterly earnings data on Tuesday. The medical technology company reported ($0.15) earnings per share for the quarter, beating analysts...
MarketBeat·16h ago
News Placeholder
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the...
Business Wire·17h ago
News Placeholder
Inogen Announces $30 Million Share Repurchase Program
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has authorized a share...
Business Wire·17h ago
News Placeholder
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +69.23% and +0.09%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7d ago
News Placeholder
Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·8d ago
News Placeholder
Inogen (INGN) to Release Quarterly Earnings on Tuesday
Inogen (NASDAQ:INGN) will be releasing its Q4 2025 earnings after the market closes on Tuesday, February 24. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
Inogen (INGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·13d ago
<
1
2
...
>

Latest INGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.